{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Cancer",
      "Ligands",
      "Nanocarrier",
      "Targeted drug delivery",
      "Theranostic"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37466702",
  "DateCompleted": {
    "Year": "2023",
    "Month": "11",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2024",
    "Month": "01",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "07",
        "Day": "19"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00210-023-02612-4"
    ],
    "Journal": {
      "ISSN": "1432-1912",
      "JournalIssue": {
        "Volume": "396",
        "Issue": "12",
        "PubDate": {
          "Year": "2023",
          "Month": "Dec"
        }
      },
      "Title": "Naunyn-Schmiedeberg's archives of pharmacology",
      "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"
    },
    "ArticleTitle": "Ligand-based active targeting strategies for cancer theranostics.",
    "Pagination": {
      "StartPage": "3417",
      "EndPage": "3441",
      "MedlinePgn": "3417-3441"
    },
    "Abstract": {
      "AbstractText": [
        "In the past decades, for the intermediate or advanced cancerous stages, preclinical and clinical applications of nanomedicines in cancer theranostics have been extensively studied. Nevertheless, decreased specificity and poor targeting efficiency with low target concentration of theranostic are the major drawbacks of nanomedicine in employing clinical substitution over conventional systemic therapy. Consequently, ligand decorated nanocarrier-mediated targeted drug delivery system can transcend the obstructions through their enhanced retention activity and increased permeability with effective targeting. The highly efficient and specific nanocarrier-mediated ligand-based active therapy is one of the novel and promising approaches for delivery of the therapeutics for different cancers in recent years to restrict various cancer growth in vivo without harming healthy cells. The article encapsulates the features of nanocarrier-mediated ligands in augmentation of active targeting approaches of various cancers and summarizes ligand-based targeted delivery systems in treatment of cancer as plausible theranostics."
      ],
      "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, West Bengal, India."
          }
        ],
        "LastName": "Bandyopadhyay",
        "ForeName": "Anupriya",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, West Bengal, India."
          }
        ],
        "LastName": "Das",
        "ForeName": "Tuyelee",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, West Bengal, India."
          },
          {
            "Identifier": [],
            "Affiliation": "School of Pharmacy, Graphic Era Hill University, Bell Road, Clement Town, Dehradun, 248002, Uttarakhand, India."
          }
        ],
        "LastName": "Nandy",
        "ForeName": "Samapika",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "S.S. Cottage, Njarackal,, P.O.: Perinad, Kollam, 691601, Kerala, India."
          }
        ],
        "LastName": "Sahib",
        "ForeName": "Synudeen",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Advanced Materials, IAAM, Gammalkilsv\u00e4gen 18, 59053, Ulrika, Sweden."
          }
        ],
        "LastName": "Preetam",
        "ForeName": "Subham",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biomedical Sciences, School of Bio Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, 632014, India."
          }
        ],
        "LastName": "Gopalakrishnan",
        "ForeName": "Abilash Valsala",
        "Initials": "AV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073, West Bengal, India. abhijit.dbs@presiuniv.ac.in."
          }
        ],
        "LastName": "Dey",
        "ForeName": "Abhijit",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol",
    "NlmUniqueID": "0326264",
    "ISSNLinking": "0028-1298"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Ligands"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Drug Carriers"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Precision Medicine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ligands"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Delivery Systems"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nanomedicine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nanoparticles"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Carriers"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Agents"
    }
  ]
}